AHN-12 (Yttrium-90 labeled anti-CD45 monoclonal antibody)

AHN-12 · Masonic Cancer Center, University of Minnesota

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AHN-12 (Yttrium-90 labeled anti-CD45 monoclonal antibody), covering 2017-11-29 to 2017-11-29. Get the full timeline:

Most recent: Clinical Trial Update: Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia [Phase 1]

See pricing